Access Statistics for Katharina Elisabeth Blankart

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Hard Look at “Soft” Cost‐control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany 0 0 1 13 2 7 13 44
A hard look at soft cost-control measures in healthcare organizations: Evidence from preferred drug policies in Germany 0 0 0 12 7 10 12 50
The Effects of Off-label Drug Use on Disability and Medical Expenditure 0 0 0 9 3 7 9 22
The effects of off-label drug use on disability and medical expenditure 0 0 0 2 5 6 7 16
Total Working Papers 0 0 1 36 17 30 41 132


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention 0 0 0 3 5 6 8 87
A systematic review of coverage decision-making on health technologies—Evidence from the real world 0 0 0 20 3 4 4 79
Analysing coverage decision-making: opening Pandora’s box? 0 0 0 3 1 1 2 37
Are patients more adherent to newer drugs? 0 0 0 1 1 1 4 28
Arzneimittel: Placebo bei Engpassbekämpfung 0 0 0 1 0 1 1 5
Dispensing behaviour of pharmacies in prescription drug markets 0 0 0 4 2 4 6 40
Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and Denmark 0 0 0 1 0 1 3 36
Early Benefit Assessment of Pharmaceuticals in Germany 0 0 1 1 3 3 4 7
Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation 0 0 0 0 2 3 3 3
Funding Decisions for Newborn Screening: A Comparative Review of 22 Decision Processes in Europe 0 0 0 1 0 1 3 4
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia 0 0 0 10 3 3 4 56
Improving Service Provision - The Health Care Services' Perspective 0 0 0 0 10 11 16 26
Insurance barriers and inequalities in health care access: evidence from dual practice 0 0 0 1 3 6 14 21
Link between Process and Appraisal in Coverage Decisions 0 0 0 0 3 5 5 5
Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany 0 0 0 0 1 1 3 3
Policy as a strategy to innovate in health care? A content analysis of innovation policies in Germany, 1994–2017 0 0 0 1 0 1 2 8
Regional Innovation Systems of Medical Technology: A knowledge production function of cardiovascular research and funding in Europe 0 0 1 2 3 5 11 16
The challenges of regulatory pluralism 0 0 0 0 4 5 8 9
The diffusion of generics after patent expiry in Germany 0 0 1 10 1 2 6 71
The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany 0 0 0 5 3 3 6 41
The impact of physician-level drug budgets on prescribing behavior 0 0 0 5 2 6 7 32
To Seek Program Accreditation, Innovation, or Both?—Examining the Interdependencies in High-Reliability Health Care Organizations 0 0 0 2 2 4 6 10
Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis 0 0 0 5 1 1 5 45
Total Journal Articles 0 0 3 76 53 78 131 669


Statistics updated 2026-02-12